Methylene Blue (Akorn, Inc.)
Welcome to the PulseAid listing for the Methylene Blue drug offered from Akorn, Inc.. This Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Methylene Blue |
SUBSTANCE NAME: | METHYLENE BLUE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2009-04-01 |
END MARKETING DATE: | 0000-00-00 |
Methylene Blue HUMAN PRESCRIPTION DRUG Details:
Item Description | Methylene Blue from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2009-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-504_a9e3194b-34a3-4012-9f1e-ac30e3e31377 |
PRODUCT NDC: | 17478-504 |
APPLICATION NUMBER: | |
Other METHYLENE BLUE Pharmaceutical Manufacturers / Labelers: